Medicare Enrolled
Dr. Francisco Rodriguez, MD
Hematology · Fort Myers, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rodriguez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodriguez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rodriguez
Dr. Francisco Rodriguez is a hematology specialist in Fort Myers, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rodriguez performed 166,912 Medicare services across 3,274 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rodriguez received a total of $3,717 from 50 pharmaceutical and/or device companies across 173 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rodriguez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 29% volume in FL
$3,717 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 86127 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗166,912
Medicare services
Top 29% in FL for hematology
3,274
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,785 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 31,400 | $43 | $137 |
| Iron infusion (Feraheme) | 22,950 | $0 | $4 |
| Nivolumab injection (Opdivo) | 22,220 | $24 | $72 |
| Anti-nausea injection (aprepitant) | 20,670 | $1 | $5 |
| Oxaliplatin chemotherapy injection | 14,000 | $0 | $12 |
| Filgrastim injection (Zarxio) for white blood cells | 10,440 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 8,040 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 7,260 | $6 | $23 |
| Daratumumab injection (Darzalex) | 6,660 | $38 | $110 |
| Azacitidine chemotherapy injection | 4,100 | $0 | $4 |
| Dexamethasone injection (steroid) | 2,643 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,940 | $1 | $28 |
| Infliximab infusion (Remicade) | 1,910 | $26 | $124 |
| Complete blood count (CBC) with differential | 1,824 | $8 | $29 |
| Blood draw (venipuncture) | 1,455 | $8 | $9 |
| Injection, bortezomib, 0.1 mg | 1,225 | $5 | $113 |
| Injection, leucovorin calcium, per 50 mg | 1,103 | $3 | $12 |
| Office visit, established patient (30-39 min) | 670 | $100 | $339 |
| Administration of chemotherapy into vein, 1 hour or less | 668 | $103 | $378 |
| Injection, fluorouracil, 500 mg | 634 | $2 | $7 |
| Injection of additional new drug or substance into vein | 591 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 552 | $0 | $9 |
| Drug injection, under skin or into muscle | 545 | $11 | $69 |
| Injection, cisplatin, powder or solution, 10 mg | 273 | $2 | $13 |
| Office visit, established patient (20-29 min) | 259 | $63 | $239 |
| Infusion, normal saline solution , 1000 cc | 244 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 221 | $23 | $84 |
| Injection, carboplatin, 50 mg | 198 | $2 | $41 |
| Infusion into a vein for hydration, each additional hour | 196 | $10 | $42 |
| Administration of chemotherapy into vein, each additional hour | 196 | $23 | $79 |
| Infusion into a vein for hydration, 31-60 minutes | 185 | $26 | $156 |
| Administration of additional new drug or substance into vein, 1 hour or less | 153 | $52 | $178 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 142 | $50 | $189 |
| Injection, diphenhydramine hcl, up to 50 mg | 139 | $1 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 122 | $1 | $6 |
| Injection, zoledronic acid, 1 mg | 110 | $6 | $69 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 101 | $135 | $637 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 98 | $18 | $59 |
| Administration of additional new drug or substance into vein using push technique | 96 | $45 | $170 |
| Office visit, established patient, complex (40-54 min) | 93 | $141 | $474 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 91 | $58 | $206 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 81 | $3 | $11 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 62 | $137 | $562 |
| Automated urinalysis | 56 | $2 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 56 | $16 | $56 |
| New patient office visit (45-59 min) | 52 | $134 | $453 |
| Injection of drug or substance into vein | 49 | $29 | $156 |
| New patient office visit, complex (60-74 min) | 38 | $173 | $585 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 33 | $16 | $56 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 32 | $26 | $89 |
| Red blood count, automated test | 22 | $4 | $10 |
| Office visit, established patient (10-19 min) | 14 | $33 | $147 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.6% high complexity
81.5% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,717
Total received (2018-2024)
Avg $531/year across 7 years
Bottom 35% in FL for hematology
50
Companies
173
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,160 (85.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$557 (15.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,075
2023
$377
2022
$712
2021
$278
2020
$116
2019
$407
2018
$750
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$497
Janssen Biotech, Inc.
$365
E.R. Squibb & Sons, L.L.C.
$266
Agios Pharmaceuticals, Inc.
$191
Gilead Sciences, Inc.
$190
Astellas Pharma US Inc
$164
Shire North American Group Inc
$158
NanoString Technologies, Inc.
$155
Merck Sharp & Dohme Corporation
$146
Takeda Pharmaceuticals U.S.A., Inc.
$129
SpringWorks Therapeutics, Inc.
$121
Seagen Inc.
$85
Foundation Medicine, Inc.
$83
Incyte Corporation
$79
EMD Serono, Inc.
$72
Medtronic, Inc.
$70
GENZYME CORPORATION
$66
Merck Sharp & Dohme LLC
$52
AstraZeneca Pharmaceuticals LP
$52
Lilly USA, LLC
$51
Genentech USA, Inc.
$47
Kedrion Biopharma, Inc.
$40
CSL Behring
$38
Novartis Pharmaceuticals Corporation
$36
Bayer HealthCare Pharmaceuticals Inc.
$34
Lundbeck LLC
$32
AVEO Pharmaceuticals, Inc.
$32
Pharmacosmos Therapeutics Inc.
$31
AbbVie, Inc.
$30
Daiichi Sankyo Inc.
$30
ARRAY BIOPHARMA INC
$29
PharmaEssentia USA Corporation
$28
Rhodes Pharmaceuticals L.P.
$27
TAIHO ONCOLOGY, INC.
$27
ADC Therapeutics America, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Exelixis Inc.
$20
Amgen Inc.
$19
Celgene Corporation
$18
Janssen Pharmaceuticals, Inc
$18
Aveo Pharmaceuticals, Inc.
$18
GlaxoSmithKline, LLC.
$18
ABBVIE INC.
$16
CTI BioPharma Corp.
$15
Dendreon Pharmaceuticals LLC
$14
Spectrum Pharmaceuticals Inc.
$13
Dova Pharmaceuticals
$13
Sirtex Medical Inc
$8
Veracyte, Inc.
$3
Top 3 companies account for 30.4% of total payments
Associated products mentioned in payments ›
ALUNBRIG · Albuked · Aptensio XR · BAVENCIO · BESREMI · Bavencio · CABOMETYX · CALQUENCE · CEREZYME · COSELA · CYRAMZA · DARZALEX · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · INLYTA · Idelvion · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LYNPARZA · MONJUVI · MONOFERRIC · MYDAYIS · NINLARO · OGSIVEO · OPDIVO · OSTEOCOOL RF ABLATION · PADCEV · PEMAZYRE · PLUVICTO · PROSIGNA ASSAY · PROVENGE · Padcev · Phesgo · Pomalyst · SIR-Spheres Microspheres · Stivarga · TECVAYLI · TIBSOVO · TRINTELLIX · TUKYSA · Trodelvy · VALIANT CAPTIVIA · VERZENIO · VYVANSE · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XOSPATA · XTANDI · Xospata · Xtandi · ZEJULA · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $2 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
15
Per 100K population
1.9
County median income
$73,099
Nearest hospital
PARK ROYAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rodriguez is a mixed practice specialist, with above-average Medicare volume (top 29% in FL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rodriguez experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Rodriguez performed 31,400 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rodriguez receive payments from pharmaceutical companies?
Yes. Dr. Rodriguez received a total of $3,717 from 50 companies across 173 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodriguez's costs compare to other hematologists in Fort Myers?
Dr. Rodriguez's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodriguez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Fort Myers
Browse hematologists in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology